Related Funds
Fund Name | Location |
Aglaia Oncology Funds | Bilthoven, Netherlands, Utrecht |
Ames Seed Capital | Ames, Iowa, United States |
Authosis Capital | China, Hong Kong, Hong Kong Island |
BnL Start Partners | Borsod-Abaúj-Zemplén, Hungary, Miskolc |
Bofang Rongzhi touzi | Beijing, Beijing, China |
C.L. King & Associates | - |
Coffin Capital | Park City, United States, Utah |
Creative Startups | New Mexico, Santa Fe, United States |
Crescent Technology Ventures | England, London, United Kingdom |
Foundation for Technological Innovation | - |
Hillstar Capital | Dallas, Texas, United States |
Rockpool Investments | England, London, United Kingdom |
Shanghai Luanxiang Investment | China, Shanghai |
Tianjinvc Venture Capital Management Co., Ltd. | China, Guangdong, Tianjin |
Verifone | California, San Jose, United States |
Volksbank Berlin | - |
Wheatley Partners | Great Neck, New York, United States |
XACT Robotics | Caesarea, Hefa, Israel |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
IO Biotech | $149M | 13 Jan 2021 | Capital Region of Denmark |